All articles and news about the evolving CBD industry and the latest research on cannabidiol, the non-sterilizing cannabinoid with medicinal properties.

The CBD, or cannibidiol, is one of more than 100 compounds found in the cannabis plant known as cannabinoids.

The CDD is considered the second major component of the plant after the famous psychoactive THC. Unlike THC, it does not have a psychoactive effect that causes a "high" feeling.

In recent years, the use of CBD has become increasingly common among non-cannabis users, older adults who want to experience first-time health care and even children with autism or epilepsy whose parents want them to enjoy the benefits of cannabis without receiving a satele.

Canabidiol is a cannabinoid with medicinal properties and no analgesic effect, addiction potential or side effects.

In 2018 Confirmed The FDA in the United States is the first drug based on cannabidiol, the epidiolex for the treatment of epilepsy. In the 2019, the World Health Organization (WHO) recommended the removal of CBD from the list of hazardous substances.

As with the rest of cannabinoids identified so far, cannabidiol binds when consumed to special receptors (CB113 and CB1) found in the most important parts of the human body, brain, spine, digestive tract, and more. It affects their actions and also human health, so that science is still not able to understand it to the end.

Recent studies of the benefits of this component have led to the development of rich cannabis varieties in many percentages of cannabidiol, sometimes even up to 15% or more, known as CBD cannabis. These strains are actually in European law definitions and are also considered HMP because they contain almost no THC at all. They are used to produce oils, creams, capsules, aerosols, mineral water, and even extracts containing up to 99% CBD, which are used to mix with other products or even as 'dabs' for self consumption.

Back to top button